Published in Hepatogastroenterology on March 27, 2001
Clinical significance of lymph node metastasis in gastric cancer. World J Gastroenterol (2014) 1.25
Investigation of the recurrence patterns of gastric cancer following a curative resection. Surg Today (2011) 1.01
Correlation of tumor-positive ratio and number of perigastric lymph nodes with prognosis of patients with surgically-removed gastric carcinoma. World J Gastroenterol (2004) 0.96
Negative node count improvement prognostic prediction of the seventh edition of the TNM classification for gastric cancer. PLoS One (2013) 0.82
Protein sequence of endothelial glycoprotein IIIa derived from a cDNA clone. Identity with platelet glycoprotein IIIa and similarity to "integrin". J Biol Chem (1987) 3.87
Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Hepatology (1998) 2.52
Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Ann Surg (1996) 2.35
Influence of rejection therapy on fungal and nocardial infections in renal-transplant recipients. Lancet (1973) 2.22
Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery (2000) 2.14
Tumor necrosis factor gene polymorphism and septic shock in surgical infection. Crit Care Med (2000) 1.80
Sonography of acute right side colonic diverticulitis. Am J Surg (2001) 1.70
Alteration of the copy number and deletion of mitochondrial DNA in human hepatocellular carcinoma. Br J Cancer (2004) 1.64
Pulmonary artery perforation after Kirschner wire migration: case report and review of the literature. J Trauma (1993) 1.64
Results of curative gastrectomy for carcinoma of the distal third of the stomach. J Am Coll Surg (1996) 1.64
Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal. Br J Surg (1995) 1.58
Effects and limitations of prolonged intermittent ischaemia for hepatic resection of the cirrhotic liver. Br J Surg (1996) 1.55
Detection of serum hepatitis B, C, and D viral nucleic acids and its implications in hepatocellular carcinoma patients. J Gastroenterol (1998) 1.42
Randomized trial of gastrojejunostomy with duodenal partition versus antrectomy in unresectable periampullary cancer. Zhonghua Yi Xue Za Zhi (Taipei) (2001) 1.41
Induction of plasma protein secretion in a newly established human hepatoma cell line. Mol Cell Biol (1983) 1.39
Multiple symmetric lipomatosis in the Chinese: ultrasound, CT and MR imaging. Clin Radiol (1998) 1.38
Surgical mortality, survival, and quality of life after resection for gastric cancer in the elderly. World J Surg (2000) 1.37
Heterotopic pancreas: a difficult diagnosis. J Clin Gastroenterol (1999) 1.37
Mucin-producing neoplasms of the pancreas. Intraductal papillary and mucinous cystic neoplasms. Ann Surg (1996) 1.36
Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection. Hepatology (1992) 1.35
Mesenteric and omental cysts: an ultrasonographic and clinical study of 15 patients. Gastrointest Radiol (1991) 1.32
Stimulation of de novo synthesis of prostaglandin G/H synthase in human endothelial cells by phorbol ester. J Biol Chem (1988) 1.28
Analysis of hepatitis B virus transcripts in infected human livers. Hepatology (1989) 1.25
Relation of number of positive lymph nodes to the prognosis of patients with primary gastric adenocarcinoma. Gut (1996) 1.23
Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma. Ann Surg (2000) 1.22
Serum interleukin-6 levels reflect disease status of gastric cancer. Am J Gastroenterol (1996) 1.22
Relative prevalence of gallstone diseases in Taiwan. A nationwide cooperative study. Dig Dis Sci (1992) 1.21
Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diabetologia (1996) 1.21
Antibodies to GAD and tryptic fragments of islet 64K antigen as distinct markers for development of IDDM. Studies with identical twins. Diabetes (1992) 1.20
Modulation of HER2 expression by ferulic acid on human breast cancer MCF7 cells. Eur J Clin Invest (2006) 1.20
IL-17 expression as a possible predictive parameter for subclinical renal allograft rejection. Transpl Int (2001) 1.19
Mesohepatectomy for centrally located hepatocellular carcinoma: an appraisal of a rare procedure. J Am Coll Surg (1999) 1.19
Prospective case-controlled trial of adjuvant chemotherapy after resection of hepatocellular carcinoma. World J Surg (2000) 1.19
Characterization of glycine-N-methyltransferase-gene expression in human hepatocellular carcinoma. Int J Cancer (1998) 1.13
Hepatic resection of hepatocellular carcinoma in cirrhotic livers: is it unjustified in impaired liver function? Surgery (1996) 1.11
Right atrial thrombus presenting in a patient with heart failure and disseminated intravascular coagulation. Eur Heart J (1996) 1.11
Clinical experience with anticoagulant therapy in the management of disseminated intravascular coagulation in children. Acta Haematol (1971) 1.11
Laparoscopic cholecystectomy for cholelithiasis in a patient with situs inversus totalis. Endoscopy (1992) 1.11
Optimal surgical strategy for potentially curable serosa-involved gastric carcinoma with intraperitoneal free cancer cells. J Am Coll Surg (1997) 1.09
Prospective comparison of diagnostic peritoneal lavage, computed tomographic scanning, and ultrasonography for the diagnosis of blunt abdominal trauma. J Trauma (1993) 1.09
Prognostic significance of heat shock protein-27 expression in hepatocellular carcinoma and its relation to histologic grading and survival. Cancer (2000) 1.07
Comparison of 2-methoxyestradiol-induced, docetaxel-induced, and paclitaxel-induced apoptosis in hepatoma cells and its correlation with reactive oxygen species. Cancer (2000) 1.07
Overexpression of cyclin A but not Skp 2 correlates with the tumor relapse of human hepatocellular carcinoma. Cancer Res (1998) 1.07
Phase II and pharmacokinetic study of paclitaxel therapy for unresectable hepatocellular carcinoma patients. Br J Cancer (1998) 1.06
Paclitaxel-induced apoptosis in human gastric carcinoma cell lines. Cancer (1996) 1.06
Distribution of the superficial temporal artery in the Chinese adult. Plast Reconstr Surg (1999) 1.06
Prognostic indicators for survival after curative resection for patients with carcinoma of the stomach. Dig Dis Sci (1997) 1.05
Colonic diverticulosis in Hong Kong: distribution pattern and clinical significance. Clin Radiol (1998) 1.05
An appraisal of liver and portal vein resection for hepatocellular carcinoma with tumor thrombi extending to portal bifurcation. Arch Surg (2000) 1.05
Quality of life of patients with gastric adenocarcinoma after curative gastrectomy. World J Surg (1997) 1.04
Transcripts of the insulin-like growth factors I and II in human hepatoma. Cancer Res (1989) 1.04
International practice survey on the management of brain metastases: Third International Consensus Workshop on Palliative Radiotherapy and Symptom Control. Clin Oncol (R Coll Radiol) (2012) 1.04
Hepatolithiasis associated with cholangiocarcinoma. Br J Surg (1997) 1.03
Diverticular disease of the small bowel. Hepatogastroenterology (2000) 1.03
Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer. Br J Surg (2004) 1.03
The formation of bile canaliculi in human hepatoma cell lines. Hepatology (1990) 1.02
Parallel hybridization analysis of multiple protein kinase genes: identification of gene expression patterns characteristic of human hepatocellular carcinoma. Genomics (1998) 1.02
Surgical resection of primary hepatocellular carcinoma extending to adjacent organ(s). Eur J Surg Oncol (1996) 1.01
Diagnostic and prognostic values of CA 19-9 and CEA in periampullary cancers. J Am Coll Surg (1999) 1.01
Paraneoplastic syndromes in patients with hepatocellular carcinoma in Taiwan. Cancer (1999) 1.01
Phase II study of flutamide in the treatment of hepatocellular carcinoma. Cancer (1996) 1.01
Prognostic significance of surgical margin in hepatocellular carcinoma resection: an analysis of 165 Childs' A patients. J Surg Oncol (1997) 1.01
tie-1 protein tyrosine kinase: a novel independent prognostic marker for gastric cancer. Clin Cancer Res (1999) 1.00
High-level expression of a chemically synthesized gene for human interferon-gamma using a prokaryotic expression vector. Proc Natl Acad Sci U S A (1984) 1.00
Morbidity and mortality after radical gastrectomy for patients with carcinoma of the stomach. J Am Coll Surg (1995) 1.00
Factors affecting morbidity and mortality in biliary tract surgery. World J Surg (1992) 0.99
Bile duct injury and bile leakage in laparoscopic cholecystectomy. Br J Surg (1993) 0.97
Disseminated intravascular coagulation. Clinical experience with anticoagulant therapy in the management of disseminated intravascular coagulation in children. Proc R Soc Med (1968) 0.97
Inhibition of nuclear factor-kappaB activity is involved in E1A-mediated sensitization of radiation-induced apoptosis. J Biol Chem (1997) 0.97
Human gastric cancer kinase profile and prognostic significance of MKK4 kinase. Am J Pathol (2000) 0.96
Ki-67 expression as a prognostic marker in patients with hepatocellular carcinoma. J Gastroenterol Hepatol (1998) 0.94
Antitumor agents. 178. Synthesis and biological evaluation of substituted 2-aryl-1,8-naphthyridin-4(1H)-ones as antitumor agents that inhibit tubulin polymerization. J Med Chem (1997) 0.94
Increased nitric oxide synthase mRNA expression in the renal medulla of water-deprived rats. Kidney Int (1999) 0.94